-
Mashup Score: 14
Despite an accelerated treatment schedule and a larger treated volume than PACE-B, SBRT and MHRT had similar rates of early RTOG toxicity.
Source: www.thelancet.comCategories: General Medicine NewsTweet
-
Mashup Score: 2
Wide variation in prostate cancer detection is seen across all Prostate Imaging Reporting and Data System scores for men with suspected or biopsy-proven untreated prostate cancer who undergo MRI.
Source: pubs.rsna.orgCategories: General Medicine NewsTweet-
RT @TylerSbrt: 3/x PPV of prostate MRI varies widely by center https://t.co/P3Vw5widxe https://t.co/0rG7S00QDr
-
-
Mashup Score: 3HERMES: Randomised trial of 2-fraction or 5-fraction MRI-guided adaptive prostate radiotherapy - PubMed - 1 month(s) ago
Acceptable acute GU toxicity was seen after 2-fraction SBRT. Acute GI toxicity was low. Randomised trials are warranted to explore late toxicity and biochemical control.
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine NewsTweet-
RT @SbrtSean: HERMES: Randomised trial of 2-fraction or 5-fraction MRI-guided adaptive prostate radiotherapy. https://t.co/q0EnpBrB6d
-
-
Mashup Score: 7
Toxicity analysis without planning data is just noise.
Source: radiationeconomics.substack.comCategories: General Medicine NewsTweet-
RT @nbn426: Simul Parikh crushed the analysis on this : https://t.co/ZPnJwV2FpM
-
-
Mashup Score: 1
Piet Ost: MDT vs ENRT and MDT for Nodal Oligorecurrent Prostate Cancer / Alexandros Papachristofilou, Alfonso Gomez-Iturriaga, Almudena Zapatero, Ana-Elena
Source: oncodaily.comCategories: General Medicine NewsTweet-
RT @oncodaily: MDT vs ENRT and MDT for Nodal Oligorecurrent Prostate Cancer - @piet_ost @_ShankarSiva @ESTRO_RT https://t.co/rUYzsjAExd…
-
-
Mashup Score: 4Aitrium - Powering the future of health system data workflows - 2 month(s) ago
Powering the future of health system data workflows — secure, local, and in your hands.
Source: www.aitriumos.comCategories: General Medicine NewsTweet-
RT @AitriumOS: New Blog Post: Making Radiation Therapy Review Standard in Oncology Trials https://t.co/A8xtDFCWSH
-
-
Mashup Score: 1SABR Symposium | Radiation Therapy | Melbourne - 5 month(s) ago
Peter MacCallum Cancer Centre has been running highly successful symposia on Stereotactic Ablative Body Radiation Therapy (SABR) since 2014. In November we will once again host the SABR Symposium in Melbourne, Australia, bringing together radiation oncologists and therapists, together with physicists for this educational event.
Source: www.sabrsymposium.comCategories: General Medicine News, Oncologists2Tweet-
RT @MellyB_7: Only a few seats left! ➡️Tix on sale until Monday 6 Nov https://t.co/u9YZfdTfiT Looking forward to welcoming @AnnA25_03 @lda…
-
-
Mashup Score: 6Immune Checkpoint Inhibitors: 10-Year Results in Melanoma Are Now Out – Let's Reflect on These Impressive Advances. - 6 month(s) ago
Remarkable advances and remaining questions.
Source: www.drugdevletter.comCategories: General Medicine News, Oncologists1Tweet-
RT @Timothee_MD: @VPrasadMDMPH detailed here: https://t.co/GAC3byTNUg https://t.co/xz5tHCfQfQ
-
-
Mashup Score: 6Immune Checkpoint Inhibitors: 10-Year Results in Melanoma Are Now Out – Let's Reflect on These Impressive Advances. - 6 month(s) ago
Remarkable advances and remaining questions.
Source: www.drugdevletter.comCategories: General Medicine News, Oncologists1Tweet-
RT @Timothee_MD: @VPrasadMDMPH detailed here: https://t.co/GAC3byTNUg https://t.co/xz5tHCfQfQ
-
-
Mashup Score: 2Paul Sargos: TMT and concomitant Chemo regimen for patients with Muscle Invasive Bladder Cancer - OncoDaily - 7 month(s) ago
Paul Sargos: TMT and concomitant Chemo regimen for patients with Muscle Invasive Bladder Cancer / Camille Baudelin, cancer, Christophe Hennequin, Derek
Source: oncodaily.comCategories: General Medicine News, Oncologists1Tweet-
RT @oncodaily: TMT and concomitant Chemo regimen for patients with Muscle Invasive Bladder Cancer - @PaulSargos https://t.co/lLsnW9YuJT…
-
RT @KamalThippu: 📣#PACE - PACE C trial early toxixity data out now! 👉 https://t.co/omTlGX0wld